PRL and neoplasm: Thus, if a reduction in PRL or tumor size has not been obtained 1 year after initiation of DA treatment, a further decrease in PRL and/or tumor size may be protracted and/or insufficient, and in these patients a more thorough follow-up or multimodal treatment is warranted.